Utility of Bladder EpiCheck for Detection of Recurrent Urothelial Carcinoma

Utility of Bladder EpiCheck for Detection of Recurrent Urothelial Carcinoma A Multicenter, Prospective Blinded Study

Clinical trial to determine the performance characteristics (sensitivity and specificity) of the Bladder EpiCheck test compared to the gold standard cystoscopy and pathology.

Clinical trial to determine the performance characteristics (sensitivity and specificity) of the Bladder EpiCheck test compared to the gold standard cystoscopy and pathology in patients under monitoring for reccurrence of bladder cancer.

Inclusion Criteria:

• Patient diagnosed with incident or recurrent urothelial cell carcinoma and undergoing surveillance monitoring for urothelial cell carcinoma
• Has all urothelial cell carcinoma tumor resected within the past 12 months
• Has a plan for cystoscopic surveillance

Exclusion Criteria:

• Planning to undergo radical cystectomy or chemotherapy-radiation for UCC